Hepatitis c: The egyptian experiment
págs. 67-69
Oral anticoagulants in the treatment of atrial fibrillation: Experience in a spanish tertiary hospital
Cristóbal Gallego Muñoz, Nieves Guerrero Navarro, Mª V. Manzano Martín
págs. 71-74
Safety and efficacy assessments of male enhancement drugs and nutraceuticals in Egypt
Mohamed I Nounou, Ghada Elhaddad, Fatema Elamrawy, Ola Elagaddar, Ahmed Elyazbi, Ahmed Eshra
págs. 75-81
Analysis of oxaliplatin-related neurotoxicity in a medical oncology department
I. Ormazabal Goicoechea, María del Mar Polanco Paz, P. Sanmartín Fenollera, Visitación López-Miranda González, Montserrat Pérez Encinas
págs. 82-89
Consistency among two drug interaction compendia in onco-haematological inpatients
Mª. Ángeles Fernández de Palencia Espinosa, Alberto Espuny Miro, María Sacramento Díaz Carrasco
págs. 90-97
M. Ruano Encinar, Elena Villamañán Bueno, Ester Pérez Andreu, Catalina Lara Cátedra, Alicia Herrero Ambrosio, Rodolfo Álvarez Sala Walther
págs. 98-102
págs. 103-112
Hereditary angioedema: A case report
A Ramón Albert, Rodrigo Bonilla Peñarrubia, Carlos Devesa García, A. Soria Aledo, Pedro García Salom
págs. 126-129
Predictors and differences in patients’ self-reporting types to adverse symptomatic events
Anmar Al Taie, Hadeer Akram AbdulRazzaq, Zekiye Kübra Yilmaz, Nurgül Koramaz, Kerim Cihan Yılmaz, Fikret V Izzettin
págs. 130-135
págs. 136-138
© 2001-2024 Fundación Dialnet · Todos los derechos reservados